The role of the specialized team in the operation of continuous renal replacement therapy: a single-center experience

Table 2 Patient characteristics

	Total (N = 1104)	Pre- CRRT intervention (N = 515)	Post- CRRT intervention (N = 589)	P
Dermographic characteristics
Age, year	63.85 ± 14.39	63.05 ± 14.67	64.56 ± 14.13	0.083
Male, %	62.8	63.9	61.8	0.493
Height, cm	163.59 ± 8.53	163.63 ± 8.10	163.56 ± 8.91	0.884
Weight.kg	61.85 ± 12.07	61.65 ± 12.23	62.03 ± 11.65	0.602
BMI.kg/m²	23.07 ± 3.97	22.94 ± 3.82	23.18 ± 4.09	0.320
Surgical ICU, %	19.3	17.5	20.9	0.169
Medical ICU, %	80.7	82.5	79.1	0.169
Disease status
MAP, mmHg	79.45 ± 17.73	78.01 ± 18.49	80.72 ± 16.95	0.012
SOFA score	10.59 ± 3.98	11.03 ± 4.04	10.21 ± 3.90	0.001
Vasopressor use, %	63.5	70.5	57.4	<0.001
Ventilator use, %	61.3	68.0	55.5	<0.001
Laboratory findings
WBC, 10E3/uL	14.35 ± 10.82	13.78 ± 9.90	14.84 ± 11.55	0.103
Hb, g/dL	10.35 ± 2.40	10.34 ± 2.41	10.36 ± 2.39	0.884
Hct, %	30.71 ± 7.54	30.93 ± 8.02	30.52 ± 7.09	0.373
Platete, 10E3/uL	143.52 ± 102.86	131.03 ± 93.10	154.4 ± 109.60	<0.001
Total protein, g/dL	5.47 ± 1.09	5.36 ± 1.11	5.56 ± 1.08	0.004
Albumin, g/dL	2.95 ± 0.69	2.89 ± 0.69	3.02 ± 0.67	0.001
BUN, mg/dL	53.91 ± 31.46	55.55 ± 33.51	52.48 ± 29.51	0.106
Cr, mg/dL	3.59 ± 2.79	3.57 ± 2.86	3.61 ± 2.73	0.816
Na, mmol/L	138.06 ± 8.91	138.16 ± 10.25	137.97 ± 7.56	0.727
K, mmol/L	4.51 ± 1.10	4.53 ± 1.12	4.50 ± 1.08	0.696
TCO2, mmol/L	16.74 ± 6.13	15.84 ± 5.92	17.52 ± 6.21	<0.001
PT, INR	1.65 ± 0.97	1.66 ± 1.05	1.64 ± 0.88	0.688

CRRT continuous renal replacement therapy; BMI body mass index; ICU intensive care unit; MAP mean arterial pressure; SOFA sequential organ failure assessment; Hb hemoglobin; BUN blood urea nitrogen; Cr creatinine; tCO2 total carbon dioxide; PT prothrombin time

ISSN: 1471-2369